Malaria Vaccines Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes. In 2009, according to WHO, 214 Mn to 397 Mn clinical malaria cases were reported worldwide. However, high estimates of around 515 Mn clinical cases of P. falciparum were projected in 2002. Furthermore, malaria accounted for around 3% of the world’s total Disability Adjusted Life Years (DALYs) lost and around 10% in Africa alone. According to Centers for Disease Control and Prevention (CDC), there are around 156 types of Plasmodium species that infect various species of vertebrates. Among the numerous plasmodium species, four are considered true parasites of humans, as they utilize humans almost exclusively as a natural intermediate host: P. falciparum, P. vivax, P. ovale and P. malariae. Over 85% of malaria mortality is due to P. falciparum. Around 90% of deaths caused by malaria in Sub-Saharan Africa is primarily due to P. falciparum.
Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/37
The growing incidence of malaria globally and major players pledging for low profit margin over vaccines is expected to boost growth of the malaria vaccines market. According to World Health Organization (WHO), in 2015, approximately 292,000 children in Africa died of malaria, at very early age of 5 years. Around 306,000 fatalities associated with malaria were reported worldwide in 2015, out of which around 90% cases were reported in Africa.
Tremendous potential in the malaria vaccines market Potential for malaria vaccines is estimated to be huge as a large share of population, 90%95%, at risk of infection in Africa and South East-Asia. Advent of vaccines for adult population, would be a major breakthrough for the malaria vaccines market. Below are certain alarming statistics that embarks the need for a malaria vaccine:
•Artemisinin resistance has been detected in five countries – Laos, Cambodia, Myanmar, Vietnam and Thailand •Resistance to P. falciparum parasite against the most available anti-malarial medicines is being reported •According to the National Vector Borne Disease Control Programme, nearly 95% of the population in India reside in malaria endemic areas •There were 216 million malaria cases globally in 2016 (WHO) •Africa is the most affected region with 90% of malaria cases and deaths worldwide (WHO) •Pregnant women, children below 5 years of age, and tourists from countries with low incidence rate of malaria are identified as the most susceptible target population for malaria The global malaria vaccines market is expected to experience a huge trajectory growth with the launch of first malarial vaccine in near future.
Report includes chapters which deeply display the following deliverable about industry : • Malaria Vaccines Market Research Objective and Assumption • Malaria Vaccines Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Malaria Vaccines Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Malaria Vaccines Market, By Regions • Malaria Vaccines Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Malaria Vaccines Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Malaria Vaccines Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Malaria Vaccines Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/37
Increasing accessibility and government support towards the malaria vaccines market growth
to
contribute
The WHO has established a Global Technical Strategy for Malaria 2016-2030 (GTS) in 2015 with certain defined goals, one of them aimed at eliminating malaria in at least 10 countries. Similarly, the Indian government has established Drug Distribution Centers (DDCs) and Fever Treatment Depots (FTDs) in the rural areas for providing easy access to anti-malarial drugs. Regular monitoring and surveillance by various government programs has helped to reduce malarial cases in India from 2.03 million in 2010 to 1.1 million in 2015. Support from such national and global initiatives will drive malaria vaccines market growth during the forecast period. Many such non-profit organizations and pharmaceutical companies are conducting research on malaria vaccines. Approximately 31 trials are under progress for malaria vaccine development with a few being blood stage projects. Availability of funds and government support programs will encourage commercialization of product with successful trial results, thus boosting the malaria vaccines market growth trajectory.
About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com